Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02308527 |
Title | Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children (BEACON) |
Acronym | BEACON |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | University of Birmingham |
Indications | |
Therapies | |
Age Groups: | child | adult |
Covered Countries | NLD | ITA | IRL | GBR | FRA | ESP | DNK | CHE | BEL | AUT |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
St Anna Children's Hospital and CCRI/Studies and Statistics | Vienna | A-1090 | Austria | Details | ||
University Hospital | Gent | Belgium | Details | |||
University Hospital Rigshospitalet | Copenhagen | DK-2100 | Denmark | Details | ||
Hopital des Enfants | Toulouse | 31059 | France | Details | ||
Our Ladys Children's Hospital Dublin | Dublin | Dublin 12 | Ireland | Details | ||
Ospedale Pediatrico Bambino Gseu | Rome | 00165 | Italy | Details | ||
Natasha van Eijkelenburg | Utrecht | Netherlands | Details | |||
Instituto de Investigacion Sanitaria | Valencia | 46026 | Spain | Details | ||
Swiss Paediatric Oncology Group | Bern | 3008 | Switzerland | Details | ||
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research | Sutton | Surrey | SM2 5PT | United Kingdom | Details |